These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8878817)

  • 1. Second-generation antisense oligonucleotides: structure-activity relationships and the design of improved signal-transduction inhibitors.
    Altmann KH; Fabbro D; Dean NM; Geiger T; Monia BP; Müller M; Nicklin P
    Biochem Soc Trans; 1996 Aug; 24(3):630-7. PubMed ID: 8878817
    [No Abstract]   [Full Text] [Related]  

  • 2. Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents.
    Dean NM; McKay R; Miraglia L; Geiger T; Müller M; Fabbro D; Bennett CF
    Biochem Soc Trans; 1996 Aug; 24(3):623-9. PubMed ID: 8878816
    [No Abstract]   [Full Text] [Related]  

  • 3. First- and second-generation antisense inhibitors targeted to human c-raf kinase: in vitro and in vivo studies.
    Monia BP
    Anticancer Drug Des; 1997 Jul; 12(5):327-39. PubMed ID: 9236850
    [No Abstract]   [Full Text] [Related]  

  • 4. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
    Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
    Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.
    Monia BP; Johnston JF; Geiger T; Muller M; Fabbro D
    Nat Med; 1996 Jun; 2(6):668-75. PubMed ID: 8640558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation.
    Cioffi CL; Garay M; Johnston JF; McGraw K; Boggs RT; Hreniuk D; Monia BP
    Mol Pharmacol; 1997 Mar; 51(3):383-9. PubMed ID: 9058592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological and pharmacokinetic properties of chemically modified antisense oligonucleotide inhibitors of PKC-alpha and C-raf kinase.
    Henry SP; Monteith D; Bennett F; Levin AA
    Anticancer Drug Des; 1997 Jul; 12(5):409-20. PubMed ID: 9236856
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of antisense oligonucleotides for gene functionalization and target validation.
    Bennett CF; Cowsert LM
    Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of the pim-1 protooncogene by chimeric oligodeoxyribonucleotides composed of alpha- and beta-anomeric fragments.
    Gottikh M; Baud-Demattei MV; Lescot E; Giorgi-Renault S; Shabarova Z; Dautry F; Malvy C; Bertrand JR
    Gene; 1994 Nov; 149(1):5-12. PubMed ID: 7958988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward antisense oligonucleotide therapy for cancer: ISIS compounds in clinical development.
    Holmlund JT; Monia BP; Kwoh TJ; Dorr FA
    Curr Opin Mol Ther; 1999 Jun; 1(3):372-85. PubMed ID: 11713802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of sequence motifs in oligonucleotides whose presence is correlated with antisense activity.
    Matveeva OV; Tsodikov AD; Giddings M; Freier SM; Wyatt JR; Spiridonov AN; Shabalina SA; Gesteland RF; Atkins JF
    Nucleic Acids Res; 2000 Aug; 28(15):2862-5. PubMed ID: 10908347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective gene therapy for proliferative disorders: sense and antisense.
    Indolfi C; Chiariello M; Avvedimento EV
    Nat Med; 1996 Jun; 2(6):634-5. PubMed ID: 8640548
    [No Abstract]   [Full Text] [Related]  

  • 13. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
    Cacace AM; Ueffing M; Philipp A; Han EK; Kolch W; Weinstein IB
    Oncogene; 1996 Dec; 13(12):2517-26. PubMed ID: 9000126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo.
    Monia BP; Sasmor H; Johnston JF; Freier SM; Lesnik EA; Muller M; Geiger T; Altmann KH; Moser H; Fabbro D
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15481-4. PubMed ID: 8986837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O; Hacker NF; Cho-Chung YS
    Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational selection of antisense oligonucleotide sequences.
    Smith L; Andersen KB; Hovgaard L; Jaroszewski JW
    Eur J Pharm Sci; 2000 Sep; 11(3):191-8. PubMed ID: 11042224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
    Wingett D; Long A; Kelleher D; Magnuson NS
    J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
    Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
    J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines.
    Muszynski KW; Ruscetti FW; Gooya JM; Linnekin DM; Keller JR
    Stem Cells; 1997; 15(1):63-72. PubMed ID: 9007224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
    Wang XY; Repasky E; Liu HT
    Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.